Weight Management Interventions for Adults With Idiopathic Intracranial Hypertension
Source : https://n.neurology.org/content/101/21/e2138.long
Idiopathic intracranial hypertension (IIH) is associated with obesity; however, there is a lack of clinical consensus on how to manage weight in IIH. The aim of this systematic review was...
The biological drivers of obesity may explain why short-term weight management interventions are often insufficient for long-term disease remission. The hierarchy of effect in weight loss methods seems to be analogous to the reduction of ICP, with bariatric surgery having the most robust evidence for effective treatment of obesity in the IIH...
Researchers review various high-impact studies that link epigenetics with metabolic syndrome by comparing each study population, methylation effects, and strengths and weaknesses of each research.
Irisin and Cardiometabolic Disorders in Obesity: a Systematic Review
Source : https://www.hindawi.com/journals/iji/2023/5810157/
Overweight and obesity are global health issues, impacting a significant portion of young adults. Obesity is a complex condition influenced by genetics and environmental factors, leading to increased susceptibility to...
The review suggests that irisin plays a significant role as both a preventive measure and a biomarker for comorbidities linked to obesity and cardiometabolic disorders.
Effect of Combined Administration of Acyl-CoA: Cholesterol Acyltransferase 1 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonist on a Rodent Model of Diet-Induced Obesity
Source : https://www.sciencedirect.com/science/article/abs/pii/S0006291X23012585?via=ihub
A glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide was approved for the treatment of obesity by the Food and Drug Administration. Howev...
Collectively, these findings suggest combining semaglutide and avasimibe could be an effective approach to weight management.
Impact of a Pharmacist-Led Weight Management Service in a Cardiology Clinic
Source : https://pubmed.ncbi.nlm.nih.gov/37944862/
Pharmacist-led management of GLP-1 RA in patients with obesity or overweight led to clinically significant weight loss and improvements in weight-related comorbidities.
Pharmacist-led management of GLP-1 RA in patients with obesity or overweight led to clinically significant weight loss and improvements in weight-related comorbidities.